| | | | Index Performance | | Index | Sensex | Nifty | | Open | 18,120.22 | 5,283.75 | | High | 18,129.18 | 5,314.30 | | Low | 17,683.51 | 5,142.25 | | Today's Cls | 17,758.64 | 5,167.60 | | Prev Cls | 18,091.94 | 5,280.80 | | Change | -333.30 | -113.20 | | % Change | -1.84 | -2.14 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Nicholas Piramal | 320.00 | 7.76 | | Sun Pharma | 1,131.00 | 6.79 | | Asian Paints | 1,172.40 | 6.15 | | Lupin | 544.95 | 5.90 | | Raymond | 358.00 | 5.45 | | Losers | | Aurobindo Pharma | 332.80 | -12.06 | | Lanco Infra | 482.35 | -9.08 | | Titan Industries | 1,161.30 | -8.13 | | IVR Prime | 270.80 | -8.08 | | Brigade Enterprises | 299.60 | -7.82 | | | Market Statistics | | - | BSE | NSE | | Advances | 726 | 275 | | Declines | 2,018 | 907 | | Unchanged | 43 | 13 | | | | | | Market Commentary | | | Market slips below 18,000 again | | Broad-based selling on the back of the weakness in global markets saw the Sensex shed 333 points for the day. | | Across-the-board selling saw the market slip by 1.84% as the Sensex followed the weak international markets. Despite opening on a positive note at 18,120, the Sensex | | | | quickly slipped in the red and the market fell further as the sentiment turned extremely bearish. Europe's largest bank by assets, UBS AG reported record loss of about $14 billion on assets infected by subprime mortgages in the US also dampened the sentiment. The sharp fall in the heavyweights and a correction in oil, consumer durables, and FMCG stocks dragged the index below the 17,700 mark in the afternoon to touch the day's low of 17,684, down 408 points. The market remained nervous thereafter and the Sensex finally closed with losses of 333 points at 17,759, while the Nifty shed 113 points to close at 5,168. | | | Movers & Shakers | - Aurobindo Pharma tumbled as the stand-alone revenues of the company declined by 3.3% to Rs510.8 crore in Q3FY2008.
- Andhra Bank slipped though the bank reported a profit after tax (PAT) of Rs159 crore for Q3FY2008, a growth of 16.7% year on year (yoy) and 5.2% quarter on quarter.
- M&M closed in the red despite the company reported a revenue growth of 14.1% yoy to Rs2,940.2 crore in Q3FY2008.
- Bajaj Auto fell on reporting a 2.6% year-on-year decline in its revenues to Rs2,501.7 crore in Q3FY2008.
- Sun Pharmaceuticals surged as the consolidated net sales of the company grew by 48.96% yoy to Rs804.0 crore in Q3FY2008.
| | | |
The breadth of the market was weak. Of the 2,787 stocks traded on the BSE, 2,018 stocks declined, 726 stocks advanced and 43 stocks ended unchanged. The sectoral indices were largely weak. The BSE Oil & Gas index lost 4.45%, the BSE Power index declined by 2.88% and the BSE CD shed 2.73% and the rest closed with marginal losses.
Several heavyweights took a sharp tumble on late selling pressure. Among power stocks, Reliance Energy slipped and shed 5.44% at Rs1,992 and NTPC tumbled by 4.70% at Rs202. Among the other major losers HLL slumped by 5.14% at Rs197, ONGC lost 4.94% at Rs969, Reliance Communications slipped by 4.74% at Rs612, Reliance Industries dipped 4.12% at Rs2,470 and Bajaj Auto shed 3.26% at Rs2,301. Select counters, however, ended in the green. BHEL advanced by 1.82% each at Rs2,089, HDFC gained 1.53% at Rs2,894 and Tata Steel added 1.02% at Rs724.
Over 1.58 crore Reliance Natural Resources shares changed hands on the BSE followed by Ispat Industries (1.04 crore shares), Reliance Petroleum (94.05 lakh shares), Essar Oil (94.49 lakh shares) and Himachal Futuristic Communications (63.17 lakh shares).
Valuewise, Reliance Natural Resources registered a turnover of Rs223 crore on the BSE followed by Essar Oil (Rs217 crore), Reliance Energy (Rs178 crore), Reliance Petroleum (Rs155 crore) and Reliance Capital (Rs138 crore).
| | | | | | | | European Indices at 16:08 IST on 30-01-2008 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 | 5839.30 | -45.90 | -0.78 | | CAC 40 Index | 4856.76 | -84.69 | -1.71 | | Dax Index | 6847.19 | -45.35 | -0.66 | | | | | | | | | | | Asian Indices at close on 30-01-2008 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei | 13345.03 | -133.83 | -0.99 | | Hang Seng | 23653.69 | -638.11 | -2.63 | | Kospi Composite | 1589.06 | -45.85 | -2.98 | | Straits Times | 3000.03 | -49.87 | -1.64 | | Jakarta Composite | 2610.36 | 2.52 | 0.10 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
